Skip to content

Evolus EOLS Issuance of common stock in connection with incentive equity plan

Issuance of common stock in connection with incentive equity plan at other companies

Strattec Security logo
Strattec SecuritySTRT
$15K-6.3%
Willdan Group logo
Willdan GroupWLDN
$1.92M+29.4%
Bank of Marin Bancorp logo
Bank of Marin BancorpBMRC
$9K+12.5%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$380K
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$73.5K
Simmons First National logo
Simmons First NationalSFNC
$838K+301%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept eols:ProceedsFromPaymentsForIssuanceOfCommonStockInConnectionWithEquityIncentivePlan.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's issuance of common stock in connection with incentive equity plan.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's issuance of common stock in connection with incentive equity plan?
Evolus (EOLS) reported issuance of common stock in connection with incentive equity plan of $0 in Q1 2026.
How has Evolus's issuance of common stock in connection with incentive equity plan changed year-over-year?
Evolus's issuance of common stock in connection with incentive equity plan decreased by 100.0% year-over-year, from $742K to $0.
What is the long-term trend for Evolus's issuance of common stock in connection with incentive equity plan?
Over 4 years (2021 to 2025), Evolus's issuance of common stock in connection with incentive equity plan has grown at a 15.4% compound annual growth rate (CAGR), from $656K to $1.16M.
What does issuance of common stock in connection with incentive equity plan mean?
This metric captures the cash proceeds received by the company resulting from the issuance of common stock to employees or directors under incentive equity plans, such as stock option exercises. It serves as a measure of the capital inflow generated through employee compensation programs rather than traditional market financing. Analyzing this helps investors understand the dilution impact and the cash-generating potential of the company's equity-based incentive structures.